Skip to content

Standex International SXI Scientific Group — Goodwill Acquired

Other segment segments

Electronics Products Group
$0
Engraving Group
$0

Similar metrics at other companies

Republic Services logo
RSGGroup 3 — Goodwill, Acquired During Period
$25M-95.2%
Republic Services logo
RSGGroup 2 — Goodwill, Acquired During Period
$56M+47.4%
Cognizant logo
CTSHHealth Sciences — Goodwill, Acquired During Period
$0-100%
Republic Services logo
RSGGroup 1 — Goodwill, Acquired During Period
$137M+303%
Sherwin-Williams logo
SHWConsumer Brands Group — Goodwill Acquired
$61.95M
Labcorp Holdings logo
LHBiopharma Laboratory Services — Goodwill acquired, excluding measurement period adjustments
$0

Other financials

Income statement

See full
Revenue$224.6M+8.1%
Net income$68.5M+201%

Balance sheet

See full
Cash & equivalents$103.7M-5.5%
Total debt$521.9M-16.6%
Total equity$754.2M+9.8%
Total assets$1.5B-1.8%

Cash flow

See full
Operating cash flow$11.7M+23.1%
CapEx$5.6M-7.9%
Free cash flow$6.2M+77.5%

Valuation

See full
Market cap$3.83B+60.8%

Profitability

See full
Net margin3.2%
FCF margin7.5%

Returns & leverage

See full
Return on equity16.7%+7.3pp
Debt / equity0.7×-0.2×
Current ratio-0.4×

Where this comes from

Reported directly by Standex International in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The official record: Standex International’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Standex International's scientific group — goodwill acquired.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Standex International's scientific group — goodwill acquired?
Standex International (SXI) reported scientific group — goodwill acquired of $0 in Q1 2026.
What does scientific group — goodwill acquired mean?
The value of goodwill recognized specifically from business combinations completed within the reporting period for the Scientific Group. This indicates the segment's inorganic growth activity and the capital deployed to expand its scientific product portfolio.